Lateral Epicondylitis Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: L6905A92C2D4EN
Market Monitor Global

Abstracts

Lateral epicondylitis is prevalent among patients suffering from osteoarthritis, bursa inflammation, and radio-humeral bursitis.

This report contains market size and forecasts of Lateral Epicondylitis Treatment in Global, including the following market information:

Global Lateral Epicondylitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lateral Epicondylitis Treatment market was valued at 11620 million in 2021 and is projected to reach US$ 14640 million by 2028, at a CAGR of 3.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-surgical treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lateral Epicondylitis Treatment include Bayer AG, GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck Sharp & Dohme Corp. and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lateral Epicondylitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lateral Epicondylitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lateral Epicondylitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Non-surgical treatment
• Surgical treatment

Global Lateral Epicondylitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lateral Epicondylitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Athlete
• Others

Global Lateral Epicondylitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lateral Epicondylitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lateral Epicondylitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lateral Epicondylitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer AG
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.
• Merck Sharp & Dohme Corp.
• Pfizer Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lateral Epicondylitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lateral Epicondylitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LATERAL EPICONDYLITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Lateral Epicondylitis Treatment Market Size: 2021 VS 2028
2.2 Global Lateral Epicondylitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lateral Epicondylitis Treatment Players in Global Market
3.2 Top Global Lateral Epicondylitis Treatment Companies Ranked by Revenue
3.3 Global Lateral Epicondylitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Lateral Epicondylitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lateral Epicondylitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lateral Epicondylitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Lateral Epicondylitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lateral Epicondylitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lateral Epicondylitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Non-surgical treatment
  4.1.3 Surgical treatment
4.2 By Type - Global Lateral Epicondylitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Lateral Epicondylitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Lateral Epicondylitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lateral Epicondylitis Treatment Market Size, 2021 & 2028
  5.1.2 Athlete
  5.1.3 Others
5.2 By Application - Global Lateral Epicondylitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Lateral Epicondylitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Lateral Epicondylitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lateral Epicondylitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Lateral Epicondylitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Lateral Epicondylitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Lateral Epicondylitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.3.2 US Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.3.3 Canada Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Lateral Epicondylitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.4.2 Germany Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.3 France Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.5 Italy Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.6 Russia Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Lateral Epicondylitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.5.2 China Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.3 Japan Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.6 India Lateral Epicondylitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Lateral Epicondylitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.7.3 Israel Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.7.5 UAE Lateral Epicondylitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Corporate Summary
  7.1.2 Bayer AG Business Overview
  7.1.3 Bayer AG Lateral Epicondylitis Treatment Major Product Offerings
  7.1.4 Bayer AG Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Bayer AG Key News
7.2 GlaxoSmithKline plc.
  7.2.1 GlaxoSmithKline plc. Corporate Summary
  7.2.2 GlaxoSmithKline plc. Business Overview
  7.2.3 GlaxoSmithKline plc. Lateral Epicondylitis Treatment Major Product Offerings
  7.2.4 GlaxoSmithKline plc. Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline plc. Key News
7.3 Johnson & Johnson Services, Inc.
  7.3.1 Johnson & Johnson Services, Inc. Corporate Summary
  7.3.2 Johnson & Johnson Services, Inc. Business Overview
  7.3.3 Johnson & Johnson Services, Inc. Lateral Epicondylitis Treatment Major Product Offerings
  7.3.4 Johnson & Johnson Services, Inc. Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Services, Inc. Key News
7.4 Merck Sharp & Dohme Corp.
  7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
  7.4.2 Merck Sharp & Dohme Corp. Business Overview
  7.4.3 Merck Sharp & Dohme Corp. Lateral Epicondylitis Treatment Major Product Offerings
  7.4.4 Merck Sharp & Dohme Corp. Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Merck Sharp & Dohme Corp. Key News
7.5 Pfizer Inc.
  7.5.1 Pfizer Inc. Corporate Summary
  7.5.2 Pfizer Inc. Business Overview
  7.5.3 Pfizer Inc. Lateral Epicondylitis Treatment Major Product Offerings
  7.5.4 Pfizer Inc. Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lateral Epicondylitis Treatment Market Opportunities & Trends in Global Market
Table 2. Lateral Epicondylitis Treatment Market Drivers in Global Market
Table 3. Lateral Epicondylitis Treatment Market Restraints in Global Market
Table 4. Key Players of Lateral Epicondylitis Treatment in Global Market
Table 5. Top Lateral Epicondylitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lateral Epicondylitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lateral Epicondylitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lateral Epicondylitis Treatment Product Type
Table 9. List of Global Tier 1 Lateral Epicondylitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lateral Epicondylitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lateral Epicondylitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lateral Epicondylitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Lateral Epicondylitis Treatment Product Offerings
Table 32. Bayer AG Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline plc. Corporate Summary
Table 34. GlaxoSmithKline plc. Lateral Epicondylitis Treatment Product Offerings
Table 35. GlaxoSmithKline plc. Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services, Inc. Corporate Summary
Table 37. Johnson & Johnson Services, Inc. Lateral Epicondylitis Treatment Product Offerings
Table 38. Johnson & Johnson Services, Inc. Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Merck Sharp & Dohme Corp. Corporate Summary
Table 40. Merck Sharp & Dohme Corp. Lateral Epicondylitis Treatment Product Offerings
Table 41. Merck Sharp & Dohme Corp. Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Inc. Corporate Summary
Table 43. Pfizer Inc. Lateral Epicondylitis Treatment Product Offerings
Table 44. Pfizer Inc. Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lateral Epicondylitis Treatment Segment by Type in 2021
Figure 2. Lateral Epicondylitis Treatment Segment by Application in 2021
Figure 3. Global Lateral Epicondylitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lateral Epicondylitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lateral Epicondylitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lateral Epicondylitis Treatment Revenue in 2021
Figure 8. By Type - Global Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline plc. Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services, Inc. Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Sharp & Dohme Corp. Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Inc. Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)